Stock Track | LifeTech Scientific Plummets 5.11% Intraday After Reporting 33-34% Profit Drop in 2025 Annual Results

Stock Track
Mar 31

LifeTech Scientific's stock plummeted 5.11% during intraday trading on Tuesday, following the release of its annual financial results for 2025 which showed a significant decline in profitability despite modest revenue growth.

The company reported that while revenue increased by approximately 5.1% to RMB 1.37 billion, profit attributable to shareholders dropped sharply by 33-34% year-on-year. The decline in earnings was attributed to various factors impacting the company's bottom line, with the board not recommending a final dividend for the year.

Investors reacted negatively to the substantial profit decline, which overshadowed the modest revenue growth driven primarily by increased sales of covered stents in the company's peripheral vascular diseases business segment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10